Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens

Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer

(2015) C. Jenkinson et al.   Journal of Proteomics

Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection

(2014) Darragh P. O'Brien et al.   CLINICAL CANCER RESEARCH

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

EMT and Dissemination Precede Pancreatic Tumor Formation

(2012) Andrew D. Rhim et al.   CELL

Genetic Basis of Pancreas Cancer Development and Progression: Insights from Whole-Exome and Whole-Genome Sequencing

(2012) C. A. Iacobuzio-Donahue et al.   CLINICAL CANCER RESEARCH

The Early Detection Research Network's Specimen Reference Sets: Paving the Way for Rapid Evaluation of Potential Biomarkers

(2012) Z. Feng et al.   CLINICAL CHEMISTRY

Drugs in preclinical and early-stage clinical development for pancreatic cancer

(2012) Swapna Asuthkar et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation

(2012) Katie Partyka et al.   PROTEOMICS

Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers

(2011) Tingting Yue et al.   PLoS One

Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases

(2011) Tingting Yue et al.   PROTEOMICS

A Migration Signature and Plasma Biomarker Panel for Pancreatic Adenocarcinoma

(2010) S. Balasenthil et al.   Cancer Prevention Research

New Strategies in Pancreatic Cancer: Emerging Epidemiologic and Therapeutic Concepts

(2010) D. Li et al.   CLINICAL CANCER RESEARCH

Stromal biology and therapy in pancreatic cancer

(2010) A. Neesse et al.   GUT

Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

(2009) K. P. Olive et al.   SCIENCE